Massive Bio
Massive Bio, is an Artificial Intelligence (AI) powered platform that connects cancer patients and their treating oncologists to clinical trials while enabling pharmaceutical companies to get access to patients, mostly in community practices, and their information to speed up drug development. Massive Bio combines technology, services and oncology sub-specialist expertise to maximize trial enrollment. Massive Bio is the first company that attacks controlling patient enrollment value chain; Massive Bio does patient identification through direct direct and indirect patient acquisition channels, pre-screening through virtual site, Just-In-Time (JIT) site activation and further analyzes real world data for drug discovery. One of the major differentiating point of Massive Bio is that the Company tackles “last mile” issues for trial enrollment to eliminate site and/or financial considerations of patients. Massive Bio is the go to partner for pharmaceutical companies and CROs to get the right patient at the right time.
Domain
massivebio.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
101-250
Last Funding
$17.0M
Founded
2015
Tech Stack (37 technologies)
Frequently Asked Questions
What technologies does Massive Bio use?+
Massive Bio uses 37 technologies including Cookiebot, Facebook Pixel, Google Analytics.
What industry is Massive Bio in?+
Massive Bio operates in the Artificial Intelligence (AI) industry.
Where is Massive Bio based?+
Massive Bio is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026